Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3020 |
|
| Actual shortage: | 236 (8%) | |
| Anticipated shortage: | 18 (1%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2757 (91%) | |
Discontinuation Reports |
356 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 334 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
29 (11%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-DOXAZOSIN | 2MG | TABLET | Resolved | 2023-02-23 | 2023-03-23 | 185451 |
| APO-PRAZO TAB 2MG | 2MG | TABLET | Actual shortage | 2023-04-06 | 2024-03-27 | 188943 |
| APO-PERINDOPRIL | 2MG | TABLET | Resolved | 2023-04-21 | 2023-05-06 | 190005 |
| APO-TERAZOSIN | 2MG | TABLET | Resolved | 2023-06-16 | 2024-04-02 | 195253 |
| APO-HYDROMORPHONE | 2MG | TABLET | Resolved | 2023-09-01 | 2023-09-28 | 203548 |
| APO-ARIPIPRAZOLE | 2MG | TABLET | Resolved | 2023-11-10 | 2023-12-01 | 209901 |
| APO-ARIPIPRAZOLE | 2MG | TABLET | Resolved | 2023-11-10 | 2023-12-01 | 209904 |
| APO-PRUCALOPRIDE | 2MG | TABLET | Resolved | 2023-11-10 | 2023-12-01 | 209922 |
| APO-PERINDOPRIL | 2MG | TABLET | Resolved | 2023-11-24 | 2023-12-08 | 211502 |
| APO-HYDROMORPHONE | 2MG | TABLET | Resolved | 2023-12-01 | 2024-01-12 | 212383 |
| APO-GUANFACINE XR | 2MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-12-08 | 2024-01-12 | 212949 |
| APO-GUANFACINE XR | 2MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-12-22 | 2024-01-12 | 214232 |
| APO-ARIPIPRAZOLE | 2MG | TABLET | Resolved | 2024-03-01 | 2024-03-15 | 221099 |
| APO-ARIPIPRAZOLE | 2MG | TABLET | Resolved | 2024-03-08 | 2024-03-15 | 221708 |
| APO-TERAZOSIN | 2MG | TABLET | Actual shortage | 2024-04-26 | 2024-04-26 | 226330 |
| MYA | 3.00MG 0.02MG | TABLET | Resolved | 2017-03-11 | 2020-09-04 | 555 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 3.0G 0.375G | POWDER FOR SOLUTION | Actual shortage | 2017-03-11 | 2018-09-12 | 577 |
| ZAMINE 21 | 3.0MG 0.030MG | TABLET | Resolved | 2017-03-11 | 2020-09-04 | 558 |
| ZAMINE 28 | 3.0MG 0.030MG | TABLET | Resolved | 2017-03-11 | 2020-09-04 | 561 |
| APO-RISPERIDONE | 3.0MG | TABLET | Resolved | 2020-06-10 | 2020-07-13 | 117407 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-AMOXI SUGAR FREE | 125MG | POWDER FOR SUSPENSION | Discontinued | 2018-09-07 | 2018-09-15 | 60249 |
| APO NAPROXEN TAB 125MG | 125MG | TABLET | Discontinued | 2018-09-08 | 2019-08-08 | 60663 |
| APO-HYDROMORPHONE CR | 12MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110962 |
| APO-NIZATIDINE | 150MG | CAPSULE | Discontinued | 2017-03-13 | 2017-03-13 | 1127 |
| APO-SULIN TAB 150MG | 150mg | tablet | Discontinued | 2017-03-13 | 2017-03-13 | 1186 |
| APO-CLINDAMYCIN | 150MG | CAPSULE | To be discontinued | 2018-09-07 | 2018-12-28 | 60396 |
| APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60536 |
| APO-LAMIVUDINE | 150MG | TABLET | Discontinued | 2018-09-07 | 2019-07-13 | 60557 |
| APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2018-09-08 | 2019-02-13 | 60723 |
| APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2018-09-08 | 2018-12-28 | 60726 |
| APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2019-01-02 | 2019-01-09 | 70810 |
| ACID REDUCER | 150MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71210 |
| APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71234 |
| APO-CLINDAMYCIN | 150MG | CAPSULE | Discontinued | 2019-11-11 | 2019-11-11 | 98363 |
| APO-OXAZEPAM | 15MG | TABLET | To be discontinued | 2018-09-08 | 2018-09-08 | 60678 |
| APO-TEMAZEPAM | 15MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-14 | 65477 |
| APO-PINDOL TAB 15MG | 15MG | TABLET | Discontinued | 2022-02-09 | 2022-12-09 | 154574 |
| APO-SOTALOL | 160MG | TABLET | Discontinued | 2017-03-31 | 2018-02-05 | 4971 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60313 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60316 |